Literature DB >> 31153552

Pneumocystis jirovecii pneumonia at chest High-resolution Computed Tomography (HRCT) in non-HIV immunocompromised patients: Spectrum of findings and mimickers.

Lorenzo Cereser1, Anna Dallorto2, Anna Candoni3, Stefano Volpetti4, Elda Righi5, Chiara Zuiani6, Rossano Girometti7.   

Abstract

Pneumocystis jirovecii pneumonia (PJP) has emerged as a main issue in non Human Immunodeficiency Virus (HIV) immunocompromised hosts, exposing patients to high mortality rates, especially when the diagnosis is delayed. Since microbiological confirmation is often unfeasible or difficult to obtain, High-resolution Computed Tomography (HRCT) represents a main tool for guiding the diagnosis in the appropriate clinical scenario. Nevertheless, radiologists must be aware that PJP at HRCT is a multifaceted process, with a variety of common and less frequent findings, along with a broad spectrum of infectious (e.g., viral and certain fungal and bacterial pneumonias) and non-infectious (e.g., pulmonary oedema, diffuse alveolar haemorrhage, and drug toxicity) differential diagnoses. In this review we resume background clinical information on PJP in non-HIV immunocompromised patients, illustrate both typical and less frequent HRCT findings, and present the spectrum of infectious and non-infectious mimickers at HRCT, highlighting the similarities with PJP and providing clues for the differential diagnosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  High-resolution Computed Tomography; Immunocompromised patients; Pneumocystis jirovecii; Pneumonia

Mesh:

Year:  2019        PMID: 31153552     DOI: 10.1016/j.ejrad.2019.04.025

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  Differences and similarities of high-resolution computed tomography features between pneumocystis pneumonia and cytomegalovirus pneumonia in AIDS patients.

Authors:  Chun-Jing Du; Jing-Yuan Liu; Hui Chen; Shuo Yan; Lin Pu; Hao-Feng Xiong; Pan Xiang; Chuan-Sheng Li; Ming Zhang; Ru-Ming Xie; Bu-Dong Chen; Ang Li
Journal:  Infect Dis Poverty       Date:  2020-10-26       Impact factor: 4.520

2.  Pneumocystis jirovecii Disease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus.

Authors:  Katrien Lagrou; Sharon Chen; Henry Masur; Claudio Viscoli; Catherine F Decker; Livio Pagano; Andreas H Groll
Journal:  Clin Infect Dis       Date:  2021-03-12       Impact factor: 9.079

Review 3.  Chest-CT mimics of COVID-19 pneumonia-a review article.

Authors:  Eleonora Carlicchi; Pietro Gemma; Antonio Poerio; Antonella Caminati; Angelo Vanzulli; Maurizio Zompatori
Journal:  Emerg Radiol       Date:  2021-03-01

4.  Pneumocystis jirovecii pneumonia in a patient receiving chemotherapy for advanced prostatic cancer: a case report.

Authors:  Chen Tiantian; Yan Jin; Zhang Jing; Feng Jing; Jin Xiaoyan
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

5.  Necrotizing Granulomatous Pneumocystis Infection Presenting as a Solitary Pulmonary Nodule: A Case Report and Review of the Literature.

Authors:  Mansur Assaad; Mohamed Swalih; Apurwa Karki
Journal:  Case Rep Pulmonol       Date:  2022-07-28

6.  Strongyloides stercoralis hyperinfection syndrome mimicking pseudomembranous enteritis, complicated by Escherichia coli bacteremia and Pneumocystis jirovecii pneumonia in a patient after immunosuppressive therapy: a case report.

Authors:  De-Han Cai; Jun Wang; Xiao-Lin Fang
Journal:  BMC Infect Dis       Date:  2022-09-24       Impact factor: 3.667

7.  Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.

Authors:  Jun Won Park; Jeffrey R Curtis; Min Jung Kim; Hajeong Lee; Yeong Wook Song; Eun Bong Lee
Journal:  Arthritis Res Ther       Date:  2019-09-14       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.